Medical Board

Prof. Aaron Ciechanover

Nobel Laureate in Chemistry, 2004

Earned his Master’s degree (1970) in science and a Doctorate in medicine (1974) from the Hebrew University of Jerusalem and an honorary doctorate from the Hebrew University (2007). He is a faculty member of the Technion-Israel Institute of Technology. Prof. Ciechanover received the Nobel Prize in Chemistry for the discovery of ubiquitin mediated protein degradation. He received the prize along with Prof. Avram Hershko, and his American Colleague.

Prof. Yossi Yarden

Weitzman Institute – Rechovot, Israel Boards of Academic Institutions
, Board of Governors of the Technion – Israel Institute of Technology, 2002, Board of Governors of the The Weizmann Institute of Science, 2001

: Bioline Rx, Jerusalem, Israel, Member of the Scientific Advisory Board
Targeted Molecular Diagnostics, Westmont, IL, Chair of the Scientific Advisory Board 
GammaCan International Inc., Tel Aviv, Member of the Scientific Advisory Board 
Molecular Targeted Therapy of Cancer (MTTC), Board Member.

Prof. Victor Velculescu, Ph.D.

The Johns Hopkins

Director of Cancer Biology at the Sidney Kimmel Cancer Center as Associate Professor of Oncology and Co-University. After graduating from Stanford University with a B.S. in Biological Sciences, he enrolled in the M.D./Ph.D. program at The Johns Hopkins University. Velculescu and his team gained international recognition after identifying the genes that cause breast cancer and colon cancer.

Prof. William T. Beck, Ph.D.

UIC Distinguished Professor of Pharmacology and Molecular Genetics. Professor and Head, PD, PD Department of Biopharmaceutical Science at the University of Illinois.

Education: George Washington Univ., Washington, DC Ph.D. Johns Hopkins University, Baltimore, MD BA SUNY, Upstate Medical Center., Syracuse, NY MS Johns Hopkins University BA State University of NY, Syracuse MS George Washington University Ph.D.